• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient.

作者信息

Wang Hua Xian Elizabeth, Tang Po Yin, Oh Choon Chiat

机构信息

Department of Dermatology, Singapore General Hospital, Singapore.

Department of Pathology, Singapore General Hospital, Singapore.

出版信息

JAAD Case Rep. 2022 Jul 6;27:9-12. doi: 10.1016/j.jdcr.2022.06.036. eCollection 2022 Sep.

DOI:10.1016/j.jdcr.2022.06.036
PMID:35959092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9361210/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/d40bb6215383/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/78867821d366/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/8c9db8f309f1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/98956aeecc2c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/d40bb6215383/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/78867821d366/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/8c9db8f309f1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/98956aeecc2c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/9361210/d40bb6215383/gr4.jpg

相似文献

1
Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient.肾移植受者皮肤移植后淋巴组织增生性疾病的皮肤镜特征
JAAD Case Rep. 2022 Jul 6;27:9-12. doi: 10.1016/j.jdcr.2022.06.036. eCollection 2022 Sep.
2
Single-institution Retrospective Analysis of Prognostic Factors Influencing Very Late-onset Post-transplant Lymphoproliferative Disorder.影响移植后极晚期淋巴细胞增殖性疾病预后因素的单中心回顾性分析
Cureus. 2020 Feb 7;12(2):e6912. doi: 10.7759/cureus.6912.
3
Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.利妥昔单抗治疗及降低免疫抑制以挽救胰腺和肾脏移植受者因肉眼血尿发现的肾移植后淋巴细胞增生性疾病后的移植肾功能：一例报告
Transplant Proc. 2011 Nov;43(9):3299-301. doi: 10.1016/j.transproceed.2011.10.002.
4
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.成人实体器官移植受者中的移植后 Burkitt 淋巴瘤：利妥昔单抗（R）序贯免疫化疗，随后是环磷酰胺、多柔比星、长春新碱和泼尼松（CHOP）或 R-CHOP，在对 8 例患者的分析中是安全有效的。
Cancer. 2012 Oct 1;118(19):4715-24. doi: 10.1002/cncr.27482. Epub 2012 Mar 5.
5
Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder.利妥昔单抗治疗失败与弥漫性大 B 细胞淋巴瘤型移植后淋巴组织增生性疾病的不良预后相关。
Br J Haematol. 2020 Apr;189(1):97-105. doi: 10.1111/bjh.16304. Epub 2020 Feb 18.
6
Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.使用R-CHOP方案成功治疗利妥昔单抗耐药的爱泼斯坦-巴尔病毒相关移植后淋巴细胞增生性疾病
J Clin Exp Hematop. 2014;54(2):149-53. doi: 10.3960/jslrt.54.149.
7
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.利妥昔单抗序贯 CHOP 化疗治疗成人 B 细胞移植后淋巴组织增生性疾病（PTLD）：前瞻性国际多中心 2 期 PTLD-1 试验。
Lancet Oncol. 2012 Feb;13(2):196-206. doi: 10.1016/S1470-2045(11)70300-X. Epub 2011 Dec 13.
8
Isolated peritoneal lymphomatosis defined as post-transplant lymphoproliferative disorder after a liver transplant: A case report.孤立性腹膜淋巴瘤病定义为肝移植后的移植后淋巴细胞增生性疾病：一例报告。
World J Clin Cases. 2019 Dec 26;7(24):4299-4306. doi: 10.12998/wjcc.v7.i24.4299.
9
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.一项关于伊布替尼联合利妥昔单抗-环磷酰胺-盐酸多柔比星-长春新碱-泼尼松方案治疗 EBV 阳性弥漫性大 B 细胞淋巴瘤的 II 期研究（54179060LYM2003：IVORY 研究）：最终分析结果。
Ann Hematol. 2020 Jun;99(6):1283-1291. doi: 10.1007/s00277-020-04005-6. Epub 2020 Apr 24.
10
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.化疗免疫疗法对爱泼斯坦-巴尔病毒阳性弥漫性大B细胞淋巴瘤的反应及生存获益
Hematol Oncol. 2018 Feb;36(1):93-97. doi: 10.1002/hon.2449. Epub 2017 Jun 22.

本文引用的文献

1
Dermatoscopy of nodular/plaque-type primary cutaneous T- and B-cell lymphomas: A retrospective comparative study with pseudolymphomas and tumoral/inflammatory mimickers by the International Dermoscopy Society.结节/斑块型原发性皮肤T细胞和B细胞淋巴瘤的皮肤镜检查：国际皮肤镜协会与假性淋巴瘤及肿瘤/炎症性模仿病变的回顾性对比研究
J Am Acad Dermatol. 2022 Apr;86(4):774-781. doi: 10.1016/j.jaad.2021.10.020. Epub 2021 Oct 23.
2
Primary Cutaneous Monomorphic Post-transplant Lymphoproliferative Disorder Mimicking Squamous Cell Carcinoma In Situ.模仿原位鳞状细胞癌的原发性皮肤单形性移植后淋巴组织增生性疾病
Am J Dermatopathol. 2021 Dec 1;43(12):e234-e236. doi: 10.1097/DAD.0000000000001950.
3
Dermoscopic and trichoscopic features of primary cutaneous lymphomas - systematic review.
原发性皮肤淋巴瘤的皮肤镜和毛发镜特征——系统评价
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):1470-1484. doi: 10.1111/jdv.17219. Epub 2021 Apr 27.
4
Dermoscopy of Primary Cutaneous B-cell Lymphoma.原发性皮肤B细胞淋巴瘤的皮肤镜检查
Indian Dermatol Online J. 2019 Mar-Apr;10(2):208-209. doi: 10.4103/idoj.IDOJ_39_18.
5
Dermoscopy of Cutaneous Lymphoproliferative Disorders: Where Are We Now?皮肤淋巴组织增生性疾病的皮肤镜检查：我们现在在哪里？
Dermatology. 2018;234(3-4):131-136. doi: 10.1159/000490412. Epub 2018 Jul 20.
6
Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma.皮肤镜检查与原发性皮肤 B 细胞淋巴瘤的诊断。
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):53-56. doi: 10.1111/jdv.14549. Epub 2017 Sep 12.
7
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.移植后淋巴组织增生性疾病（PTLD）：危险因素、诊断和当前治疗策略。
Curr Hematol Malig Rep. 2013 Sep;8(3):173-83. doi: 10.1007/s11899-013-0162-5.
8
Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series.实体器官移植受者原发性皮肤移植后淋巴组织增生性疾病：一项多中心欧洲病例系列研究。
Am J Transplant. 2013 Aug;13(8):2146-53. doi: 10.1111/ajt.12281. Epub 2013 May 29.